Marcy l’Étoile (France) - June 29, 2020 – bioMérieux, a global leader in the field of in vitro diagnostics, announces that it has successfully issued today a €200 million Euro PP new debt with a top-tier European institutional investor.
The private placement will comprise two tranches: one 7-year €145 million tranche, and one 10-year €55 million tranche, bearing an aggregated annual coupon of 1.61%.
This private placement bond issue, which was completed under favorable conditions for bioMérieux, enables the Group to extend the maturity of its borrowings and continue its strategy of diversifying its sources of financing. This long term financing will serve general corporate purposes and allow bioMérieux to pursue its growth ambitions. The proceeds from this bond issue will also be partly used to refinance the existing public bond issued in 2013 for an amount of €300 million, maturing in October 2020.
The issue was arranged by BNP Paribas and Crédit Agricole CIB with the legal support of Gide Loyrette Nouel and Allen & Overy.
Download
- Filename
- biomerieux-euro_pp_bond-20200629.pdf
- Size
- 217 KB
- Format
- application/pdf